Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020



Dana Fuchs-Telem

Dana Fuchs-Telem

Director of Project Management, ATVIO Biotech Ltd
Dr. Fuchs-Telem is an expert in the field of cell therapy, having spent the past 6 years involved in the research, development, and production of numerous cell therapy products. Dana earned her BSc in Biology and MSc in genetic consultation at the Hebrew University in Jerusalem. She holds a PhD in cellular biology from Tel Aviv University, having written a thesis on the genetic causes of skin diseases. She served as a Project Manager at Pluristem Therapeutics, a cell therapy company in which she held R&D positions. She is appointed as the director of project management with expertise in cell production for the biotech sector.
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd